1
|
Riera-Sadurní J, Cañameras C, Molina M, Urrutia M, Paul-Martínez J, Graterol F, Perezpayá I, Omar T, Gelpi R, Casas Á, Cañas L, Juega J, Tovar G, Sampere J, Esteban C, Areal J, Satué CG, Bover J, Vila A. Trasplante renal y síndrome de Klippel-Trenaunay-Weber: una asociación insólita. Nefrologia 2022. [DOI: 10.1016/j.nefro.2022.11.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
|
2
|
Bover J, Bosch R, Luis Górriz J, Ureña P, Ortiz A, daSilva I, García-Trabanino RA, Hueso M, Trinidad P, Jara A, Furlano M, Gelpi R, Vila-Santandreu A, Restrepo CA, Sánchez-Baya M, Arana C, Goicoechea M, Coll V, Segura J, Gutiérrez O, Kalantar-Zadeh K, Sánchez E, Ferreiro A, García-Maset R. Kidneys also speak Spanish: Initiatives towards standardisation of our nephrology nomenclature. Nefrologia 2022; 42:223-232. [PMID: 36167667 DOI: 10.1016/j.nefroe.2022.09.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2021] [Accepted: 04/04/2021] [Indexed: 06/16/2023] Open
Affiliation(s)
- Jordi Bover
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, REDinREN, Barcelona, Spain.
| | - Ricardo Bosch
- Departamento de Biología de Sistemas, Unidad de Fisiología, Facultad de Medicina, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain
| | - José Luis Górriz
- Servicio de Nefrología, Hospital Clínico Universitario, INCLIVA, Universidad de Valencia, Valencia, Spain
| | - Pablo Ureña
- AURA Nord Saint Ouen, Saint Ouen, Francia y Department of Renal Physiology, Necker Hospital, University of Paris Descartes, París, France
| | - Alberto Ortiz
- Servicio de Nefrología e Hipertensión, IIS-Fundación Jiménez Díaz-UAM, Madrid, Spain
| | - Iara daSilva
- Servicio de Nefrología, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma, Badalona, Spain
| | - Ramón A García-Trabanino
- Centro de Hemodiálisis de San Salvador, Fondo Social de Emergencia para la Salud de Tierra Blanca, El Salvador, Spain
| | - Miguel Hueso
- Servicio de Nefrología, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Spain; Grupo de trabajo sobre BigData e Inteligencia Artificial (BigSEN) de la Sociedad Española de Nefrología, Barcelona, Spain
| | - Pedro Trinidad
- Departamento de Nefrología, HECMN siglo XXI, IMSS, Ciudad de México, Mexico
| | - Aquiles Jara
- Departamento de Nefrología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - Mónica Furlano
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, REDinREN, Barcelona, Spain; Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, Spain
| | - Rosana Gelpi
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, REDinREN, Barcelona, Spain; Servicio de Nefrología, Hospital de Caldas, Universidad de Caldas, Manizales, Colombia
| | - Ana Vila-Santandreu
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, REDinREN, Barcelona, Spain
| | - César A Restrepo
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, Spain
| | - Maya Sánchez-Baya
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, REDinREN, Barcelona, Spain; Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, Spain
| | - Carolt Arana
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, REDinREN, Barcelona, Spain; Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, Spain
| | - Marián Goicoechea
- Servicio de Nefrología, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - Verónica Coll
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, REDinREN, Barcelona, Spain; Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, Spain
| | - Julián Segura
- Servicio de Nefrología, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - Orlando Gutiérrez
- Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
| | - Kamyar Kalantar-Zadeh
- Division of Nephrology and Hypertension and Kidney Transplantation, Orange, University of California Los Angeles, Los Angeles, CA, USA
| | - Emilio Sánchez
- Servicio de Nefrología, Hospital Universitario de Cabueñes, Gijón, Spain
| | - Alejandro Ferreiro
- Centro de Nefrología, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay
| | | |
Collapse
|
3
|
Bover J, Bosch R, Górriz JL, Ureña P, Ortiz A, daSilva I, García-Trabanino RA, Hueso M, Trinidad P, Jara A, Furlano M, Gelpi R, Vila-Santandreu A, Restrepo CA, Sánchez-Baya M, Arana C, Goicoechea M, Coll V, Segura J, Gutiérrez O, Kalantar-Zadeh K, Sánchez E, Ferreiro A, García-Maset R. Kidneys also speak Spanish: Initiatives towards standardisation of our nephrology nomenclature. Nefrologia 2021; 42:S0211-6995(21)00157-0. [PMID: 34452777 DOI: 10.1016/j.nefro.2021.04.011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2021] [Accepted: 04/04/2021] [Indexed: 11/18/2022] Open
Affiliation(s)
- Jordi Bover
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, REDinREN, Barcelona, España.
| | - Ricardo Bosch
- Departamento de Biología de Sistemas, Unidad de Fisiología, Facultad de Medicina, Universidad de Alcalá, Alcalá de Henares, Madrid, España
| | - José Luis Górriz
- Servicio de Nefrología, Hospital Clínico Universitario. INCLIVA. Universidad de Valencia, Valencia, España
| | - Pablo Ureña
- AURA Nord Saint Ouen. Saint Ouen, Francia y Department of Renal Physiology. Necker Hospital, University of Paris Descartes, París, Francia
| | - Alberto Ortiz
- Servicio de Nefrología e Hipertensión. IIS-Fundación Jiménez Díaz-UAM, Madrid, España
| | - Iara daSilva
- Servicio de Nefrología, Hospital Universitari Germans Trias i Pujol, Universitat Autònoma, Badalona, España
| | - Ramón A García-Trabanino
- Centro de Hemodiálisis de San Salvador, Fondo Social de Emergencia para la Salud de Tierra Blanca, El Salvador, España
| | - Miguel Hueso
- Servicio de Nefrología, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, España; Grupo de trabajo sobre BigData e Inteligencia Artificial (BigSEN) de la Sociedad Española de Nefrología, Barcelona, España
| | - Pedro Trinidad
- Departamento de Nefrología, HECMN siglo XXI. IMSS, Ciudad de México, México
| | - Aquiles Jara
- Departamento de Nefrología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - Mónica Furlano
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, REDinREN, Barcelona, España; Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, España
| | - Rosana Gelpi
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, REDinREN, Barcelona, España; Servicio de Nefrología, Hospital de Caldas, Universidad de Caldas, Manizales, Colombia
| | - Ana Vila-Santandreu
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, REDinREN, Barcelona, España
| | - César A Restrepo
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, España
| | - Maya Sánchez-Baya
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, REDinREN, Barcelona, España; Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, España
| | - Carolt Arana
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, REDinREN, Barcelona, España; Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, España
| | - Marián Goicoechea
- Servicio de Nefrología, Hospital General Universitario Gregorio Marañón, Madrid, España
| | - Verónica Coll
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, REDinREN, Barcelona, España; Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, España
| | - Julián Segura
- Servicio de Nefrología, Hospital Universitario 12 de Octubre, Madrid, España
| | - Orlando Gutiérrez
- Division of Nephrology, Department of Medicine. University of Alabama at Birmingham, Birmingham, AL, USA
| | - Kamyar Kalantar-Zadeh
- Division of Nephrology and Hypertension and Kidney Transplantation, Orange. University of California Los Angeles, Los Angeles, California, USA
| | - Emilio Sánchez
- Servicio de Nefrología, Hospital Universitario de Cabueñes, Gijón, España
| | - Alejandro Ferreiro
- Centro de Nefrología, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay
| | | |
Collapse
|
4
|
Lloret MJ, Canal C, Di Gregorio S, Facundo Molas C, Vila Santandreu A, Serra Cabanas N, Gelpi R, Fayos De Arizon L, Arana C, Montolio D, Bardaji B, Guirado L, Bover J. MO567PILOT STUDY OF BONE RESISTANCE MEASURED IN VIVO BY IMPACT MICROINDENTATION IN KIDNEY TRANSPLANTATION. Nephrol Dial Transplant 2021. [DOI: 10.1093/ndt/gfab086.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Abstract
Background and Aims
Impact microindentation (IMI) is a new technique that measures bone material strength (BMS). Results are expressed as a BMS index (BMSi) which represents the ratio between the IMI distance [penetration of the needle-probe in patient’s bone (mid-shaft tibia)] versus a reference material (polimethylmethacrylate).
Method
Observational, prospective, single-center study. Baseline IMI (Osteoprobe®, Active Life Scientific, USA) and bone densitometry (iDXA, Lunar Health Care GE) were performed and data collected in the peritransplantation period of kidney transplant (KT) patients from May 2019 to May 2020, following our current clinical bone and transplant protocols. Based on the individual risk of fracture and current Spanish Society of Rheumathology/Nephrology guidelines, antirresorptive treatment (bisphosphonates or denosumab) was added on top of calcium and vitamin D supplements. We hereby present preliminary results of the control IMI performed 6 months after KT.
Results
Baseline IMI was performed in 45 patients, 62% men, 56±14 y/o, and a BMI of 24.9±3.5 kg/m2, reasonably controlled for classical serum bone mineral parameters. 70% were on dialysis prior to KT, 20% were diabetic, and 33.3% of women suffered from early menopause. 15.9% had a history of previous fragility fracture, 13% had a parent history of hip fracture, and 14% fell more than twice during the last year. Mean baseline FRAX® (https://www.sheffield.ac.uk/FRAX/tool.aspx?lang=sp) for a major osteoporotic fracture and hip were 4.3% and 2.3%, respectively. Baseline lumbar, femoral neck, hip and ultradistal radius DXA T-score were respectively -0.9, -1.7, -1.5, -2.0 SD. Mean BMSi was 78.5±7.6. Osteopenic/osteoporotic patients had a significantly lower BMSi than those who were not (76.3 vs 83; r = 0.37; p = 0.012). A statistically significant positive correlation was observed between BMSi and the trabecular bone score [(TBS), r = 0.346 ; p = 0.036). On a visual-analogic scale of pain, puncture was rated on average 1.1±1.6 over 10 (82% 0-2). 37.2% of patients began bisphosphonates (alendronic acid) and 9.3% denosumab. Control IMI was performed at 6 months in 24 patients, with a mean BMSi of 76.9±10.5. Mean difference between baseline and 6 months BMSi in this subgroup was 1.18±11.5. The group of patients treated with antiresorptives showed on average an increase in BMSi at 6 months, compared with a decrease in the control group (+5.2 vs -5.3; p = 0.054).
Conclusion
IMI is a technique with excellent tolerance that may offer complementary information on bone quality in the global assessment of bone resistance. IMI may allow the detection of EARLY changes in bone resistance in corticosteroid-treated KT patients with/without antiresorptives added to prophylactic treatment with calcium and vitamin D.
Collapse
Affiliation(s)
| | | | | | | | | | | | | | | | | | - Daniel Montolio
- Universitat de Barcelona School of Economics, Economics, Barcelona, Spain
| | | | | | - Jordi Bover
- Fundació Puigvert, Nephrology, Barcelona, Spain
| |
Collapse
|
5
|
Bover J, Bosch R, Ureña P, Trinidad P, Jara A, Górriz JL, Furlano M, García-Trabanino RA, Gelpi R, Ortiz A, Restrepo CA, Sánchez-Baya M, Arana C, Goicoechea M, Coll V, Segura J, Gutiérrez O, Sánchez E, Ferreiro A, García-Maset R. Kidneys also speak Spanish. Nefrologia 2021; 41:224-226. [PMID: 36166212 DOI: 10.1016/j.nefroe.2020.11.012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2020] [Accepted: 11/07/2020] [Indexed: 06/16/2023] Open
Affiliation(s)
- Jordi Bover
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, Spain.
| | - Ricardo Bosch
- Graduado en la Universidad Nacional de la Plata, Buenos Aires, Argentina; Departamento de Biología de Sistemas, Unidad de Fisiología, Facultad de Medicina, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain
| | - Pablo Ureña
- Graduado en la Pontificia Universidad Católica Madre y Maestra, Santiago de los Caballeros, República Dominicana, AURA Nord Saint Ouen, Saint Ouen, Francia, Department of Renal Physiology, Necker Hospital, University of Paris Descartes, Paris, France
| | - Pedro Trinidad
- Departamento de Nefrología, HECMN siglo XXI, IMSS, Ciudad de México, Mexico
| | - Aquiles Jara
- Departamento de Nefrología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - José Luis Górriz
- Servicio de Nefrología, Hospital Clínico Universitario, INCLIVA, Universidad de Valencia, Valencia, Spain
| | - Mónica Furlano
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, Spain; Graduada en la Universidad Nacional de Rosario, Rosario, Argentina
| | | | - Rosana Gelpi
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, Spain; Graduada en la Universidad de la República, Montevideo, Uruguay
| | - Alberto Ortiz
- Servicio de Nefrología e Hipertensión, IIS-Fundación Jiménez Díaz-UAM, Madrid, Spain
| | - César A Restrepo
- Servicio de Nefrología, Hospital de Caldas, Universidad de Caldas, Manizales, Colombia
| | - Maya Sánchez-Baya
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, Spain; Graduada en la Universidad Mayor de San Simón, Cochabamba, Bolivia
| | - Carolt Arana
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, Spain; Graduada en la Universidad Privada Antenor Orrego, Trujillo, Peru
| | - Marián Goicoechea
- Servicio de Nefrología, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - Verónica Coll
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, Spain; Graduada en la Universidad Central de Venezuela, Caracas, Venezuela
| | - Julián Segura
- Servicio de Nefrología, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - Orlando Gutiérrez
- Division of Nephrology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States
| | - Emilio Sánchez
- Servicio de Nefrología, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain
| | - Alejandro Ferreiro
- Centro de Nefrología, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay
| | | |
Collapse
|
6
|
Bover J, Bosch R, Ureña P, Trinidad P, Jara A, Górriz JL, Furlano M, García-Trabanino RA, Gelpi R, Ortiz A, Restrepo CA, Sánchez-Baya M, Arana C, Goicoechea M, Coll V, Segura J, Gutiérrez O, Sánchez E, Ferreiro A, García-Maset R. Kidneys also speak Spanish. Nefrologia 2021; 41:225-226. [PMID: 33288346 DOI: 10.1016/j.nefro.2020.11.002] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/29/2020] [Accepted: 11/07/2020] [Indexed: 01/30/2023] Open
Affiliation(s)
- Jordi Bover
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, España.
| | - Ricardo Bosch
- Graduado en la Universidad Nacional de La Plata, Buenos Aires, Argentina; Departamento de Biología de Sistemas, Unidad de Fisiología, Facultad de Medicina, Universidad de Alcalá, Alcalá de Henares, Madrid, España
| | - Pablo Ureña
- Graduado en la Pontificia Universidad Católica Madre y Maestra, Santiago de los Caballeros, República Dominicana. AURA Nord Saint Ouen, Saint Ouen, Francia. Department of Renal Physiology, Necker Hospital, University of Paris Descartes, Paris, Francia
| | - Pedro Trinidad
- Departamento de Nefrología, HECMN siglo XXI, IMSS, Ciudad de México, México
| | - Aquiles Jara
- Departamento de Nefrología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile
| | - José Luis Górriz
- Servicio de Nefrología, Hospital Clínico Universitario, INCLIVA, Universidad de Valencia, Valencia, España
| | - Mónica Furlano
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, España; Graduada en la Universidad Nacional de Rosario, Rosario, Argentina
| | | | - Rosana Gelpi
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, España; Graduada en la Universidad de la República, Montevideo, Uruguay
| | - Alberto Ortiz
- Servicio de Nefrología e Hipertensión, IIS-Fundación Jiménez Díaz-UAM, Madrid, España
| | - César A Restrepo
- Servicio de Nefrología, Hospital de Caldas, Universidad de Caldas, Manizales, Colombia
| | - Maya Sánchez-Baya
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, España; Graduada en la Universidad Mayor de San Simón, Cochabamba, Bolivia
| | - Carolt Arana
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, España; Graduada en la Universidad Privada Antenor Orrego, Trujillo, Perú
| | - Marián Goicoechea
- Servicio de Nefrología, Hospital General Universitario Gregorio Marañón, Madrid, España
| | - Verónica Coll
- Servicio de Nefrología, Fundació Puigvert, IIB Sant Pau, Universitat Autònoma, Barcelona, España; Graduada en la Universidad Central de Venezuela, Caracas, Venezuela
| | - Julián Segura
- Servicio de Nefrología, Hospital Universitario 12 de Octubre, Madrid, España
| | - Orlando Gutiérrez
- Division of Nephrology, Department of Medicine. University of Alabama at Birmingham, Birmingham, Alabama, Estados Unidos
| | - Emilio Sánchez
- Servicio de Nefrología, Hospital Universitario de Cabueñes, Gijón, Asturias, España
| | - Alejandro Ferreiro
- Centro de Nefrología, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay
| | | |
Collapse
|
7
|
Favà A, Cucchiari D, Montero N, Toapanta N, Centellas FJ, Vila-Santandreu A, Coloma A, Meneghini M, Manonelles A, Sellarés J, Torres I, Gelpi R, Lorenzo I, Ventura-Aguiar P, Cofan F, Torregrosa JV, Perelló M, Facundo C, Seron D, Oppenheimer F, Bestard O, Cruzado JM, Moreso F, Melilli E. Clinical characteristics and risk factors for severe COVID-19 in hospitalized kidney transplant recipients: A multicentric cohort study. Am J Transplant 2020; 20:3030-3041. [PMID: 32777153 PMCID: PMC7436908 DOI: 10.1111/ajt.16246] [Citation(s) in RCA: 63] [Impact Index Per Article: 15.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2020] [Revised: 07/16/2020] [Accepted: 07/24/2020] [Indexed: 01/25/2023]
Abstract
Kidney transplant recipients might be at higher risk for severe coronavirus disease 2019 (COVID-19). However, risk factors for relevant outcomes remain uncertain in this population. This is a multicentric kidney transplant cohort including 104 hospitalized patients between March 4 and April 17, 2020. Risk factors for death and acute respiratory distress syndrome (ARDS) were investigated, and clinical and laboratory data were analyzed. The mean age was 60 years. Forty-seven patients (54.8%) developed ARDS. Obesity was associated to ARDS development (OR 2.63; P = .04). Significant age differences were not found among patients developing and not developing ARDS (61.3 vs 57.8 years, P = .16). Seventy-six (73%) patients were discharged, and 28 (27%) died. Death was more common among the elderly (55 and 70.8 years, P < .001) and those with preexisting pulmonary disease (OR 2.89, P = .009). At admission, higher baseline lactate dehydrogenase (257 vs 358 IU/mL, P = .001) or ARDS conferred higher risk of death (HR 2.09, P = .044). In our cohort, ARDS was equally present among young and old kidney recipients. However, the elderly might be at higher risk of death, along with those showing higher baseline LDH at admission.
Collapse
Affiliation(s)
- Alexandre Favà
- Nephrology Department, Hospital Universitari de Bellvitge, Barcelona, Spain,Biomedical Research Institute (IDIBELL), Hospital Duran i Reynals, Barcelona, Spain
| | - David Cucchiari
- Nephrology Department, Hospital Clínic de Barcelona, Barcelona, Spain
| | - Nuria Montero
- Nephrology Department, Hospital Universitari de Bellvitge, Barcelona, Spain,Biomedical Research Institute (IDIBELL), Hospital Duran i Reynals, Barcelona, Spain,Correspondence Nuria Montero
| | - Nestor Toapanta
- Nephrology Department, Hospital de Vall d’ Hebron, Barcelona, Spain
| | | | | | - Ana Coloma
- Nephrology Department, Hospital Universitari de Bellvitge, Barcelona, Spain,Biomedical Research Institute (IDIBELL), Hospital Duran i Reynals, Barcelona, Spain
| | - Maria Meneghini
- Nephrology Department, Hospital Universitari de Bellvitge, Barcelona, Spain,Biomedical Research Institute (IDIBELL), Hospital Duran i Reynals, Barcelona, Spain
| | - Anna Manonelles
- Nephrology Department, Hospital Universitari de Bellvitge, Barcelona, Spain,Biomedical Research Institute (IDIBELL), Hospital Duran i Reynals, Barcelona, Spain
| | - Joana Sellarés
- Nephrology Department, Hospital de Vall d’ Hebron, Barcelona, Spain
| | - Irina Torres
- Nephrology Department, Hospital de Vall d’ Hebron, Barcelona, Spain
| | - Rosana Gelpi
- Nephrology Department, Fundació Puigvert, Barcelona, Spain
| | | | | | - Frederic Cofan
- Nephrology Department, Hospital Clínic de Barcelona, Barcelona, Spain
| | | | - Manel Perelló
- Nephrology Department, Hospital de Vall d’ Hebron, Barcelona, Spain
| | - Carme Facundo
- Nephrology Department, Fundació Puigvert, Barcelona, Spain
| | - Daniel Seron
- Nephrology Department, Hospital de Vall d’ Hebron, Barcelona, Spain
| | | | - Oriol Bestard
- Nephrology Department, Hospital Universitari de Bellvitge, Barcelona, Spain,Biomedical Research Institute (IDIBELL), Hospital Duran i Reynals, Barcelona, Spain
| | - Josep M. Cruzado
- Nephrology Department, Hospital Universitari de Bellvitge, Barcelona, Spain,Biomedical Research Institute (IDIBELL), Hospital Duran i Reynals, Barcelona, Spain,Josep M. Cruzado
| | - Francesc Moreso
- Nephrology Department, Hospital de Vall d’ Hebron, Barcelona, Spain
| | - Edoardo Melilli
- Nephrology Department, Hospital Universitari de Bellvitge, Barcelona, Spain,Biomedical Research Institute (IDIBELL), Hospital Duran i Reynals, Barcelona, Spain
| |
Collapse
|
8
|
Piñeiro GJ, Rovira J, Montagud-Marrahí E, Torregrosa JV, Ríos J, Cucchiari D, Ugalde-Altamirano J, Ventura-Aguiar P, Gelpi R, Palou E, Colmenero J, Navasa M, Diekmann F, Esforzado N. Kidney Graft Outcomes in High Immunological Risk Simultaneous Liver-Kidney Transplants. Liver Transpl 2020; 26:517-527. [PMID: 32011089 DOI: 10.1002/lt.25726] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/17/2019] [Accepted: 01/12/2020] [Indexed: 02/07/2023]
Abstract
Recipients of simultaneous liver-kidney transplantations (SLKTs) have a lower risk of rejection compared with recipients of kidney transplants alone. However, there is disagreement about the impact of pretransplant anti-human leukocyte antigen sensitization on patient and kidney graft survival in the long term. The aim of the study was to evaluate the impact of the recipient immunological risk and comorbidities in renal graft outcomes on SLKT. We reviewed the SLKTs performed in our center from May 1993 until September 2017. Patient and graft survival were analyzed according to the immunological risk, comorbidities, liver and kidney rejection episodes, immunosuppression, and infections. A total of 20 recipients of SLKT were considered in the high immunological risk (HIR) group, and 68 recipients were included in the low immunological risk (LIR) control group. The prevalence of hepatitis C virus infection, second renal transplant, and time on dialysis prior to transplantation were significantly higher in the HIR group. The incidence of acute kidney rejection was higher in the HIR group (P<0.01). However, death-censored kidney graft survival as well as the estimated glomerular filtration rate at follow-up were not different between the 2 groups. Comorbidities, but not the immunological risk, impact negatively on patient survival. Despite the higher incidence of rejection in the HIR SLKT group, longterm renal function and graft survival were similar to the LIR group.
Collapse
Affiliation(s)
- Gastón J Piñeiro
- Department of Nephrology and Renal Transplantation, Instituto Clínic de Nefrologia y Urologia, Hospital Clinic de Barcelona, Barcelona, Spain.,Laboratori Experimental de Nefrologia i Trasplantament, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
| | - Jordi Rovira
- Laboratori Experimental de Nefrologia i Trasplantament, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.,Red de Investigación Renal, Madrid, Spain
| | - Enrique Montagud-Marrahí
- Department of Nephrology and Renal Transplantation, Instituto Clínic de Nefrologia y Urologia, Hospital Clinic de Barcelona, Barcelona, Spain
| | - Jose V Torregrosa
- Department of Nephrology and Renal Transplantation, Instituto Clínic de Nefrologia y Urologia, Hospital Clinic de Barcelona, Barcelona, Spain
| | - José Ríos
- Medical Statistics Core Facility, IDIBAPS, Barcelona, Spain.,Biostatistics Unit, Faculty of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain
| | - David Cucchiari
- Department of Nephrology and Renal Transplantation, Instituto Clínic de Nefrologia y Urologia, Hospital Clinic de Barcelona, Barcelona, Spain.,Laboratori Experimental de Nefrologia i Trasplantament, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
| | - Jessica Ugalde-Altamirano
- Department of Nephrology and Renal Transplantation, Instituto Clínic de Nefrologia y Urologia, Hospital Clinic de Barcelona, Barcelona, Spain
| | - Pedro Ventura-Aguiar
- Department of Nephrology and Renal Transplantation, Instituto Clínic de Nefrologia y Urologia, Hospital Clinic de Barcelona, Barcelona, Spain.,Laboratori Experimental de Nefrologia i Trasplantament, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
| | - Rosana Gelpi
- Department of Nephrology and Renal Transplantation, Instituto Clínic de Nefrologia y Urologia, Hospital Clinic de Barcelona, Barcelona, Spain
| | - Eduard Palou
- Department of Immunology, Hospital Clinic de Barcelona, Barcelona, Spain
| | - Jordi Colmenero
- Liver Transplant Unit, Liver Unit, Hospital Clínic de Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red de Enfermedes Hepáticas y Digestivas, University of Barcelona, Barcelona, Spain
| | - Miquel Navasa
- Liver Transplant Unit, Liver Unit, Hospital Clínic de Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red de Enfermedes Hepáticas y Digestivas, University of Barcelona, Barcelona, Spain
| | - Fritz Diekmann
- Department of Nephrology and Renal Transplantation, Instituto Clínic de Nefrologia y Urologia, Hospital Clinic de Barcelona, Barcelona, Spain.,Laboratori Experimental de Nefrologia i Trasplantament, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.,Red de Investigación Renal, Madrid, Spain
| | - Nuria Esforzado
- Department of Nephrology and Renal Transplantation, Instituto Clínic de Nefrologia y Urologia, Hospital Clinic de Barcelona, Barcelona, Spain
| |
Collapse
|
9
|
Gelpi R, Paredes D, Rodríguez-Villar C, Roque R, Ruiz A, Adalia R, Peri-Cusí L, Sole M, Oppenheimer F, Diekmann F. The development of a predictive model of graft function in uncontrolled donors after circulatory death: validity of a pulsatile renal preservation machine cut-off value for kidney acceptance. Nephrol Dial Transplant 2019; 34:531-538. [PMID: 30085267 DOI: 10.1093/ndt/gfy241] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2017] [Accepted: 06/14/2018] [Indexed: 12/20/2022] Open
Abstract
BACKGROUND The criteria for kidney suitability in uncontrolled donors after circulatory death (uDCD) procured after regional normothermic perfusion are based on macroscopic appearance and renal haemodynamic values with final renal resistance (FRR). However, these criteria have not been analysed to predict the future graft function. This study presents a model to predict the outcome in uDCD kidneys and define the predictive FRR value. METHODS All uDCD kidney transplants performed in our hospital from 2004 to 2016 were included. Donors and recipients and pre-transplantation data are described. The endpoint was glomerular filtration rate (GFR) ≥30 mL/min at 6 months after transplantation. RESULTS A total of 194 recipients were included. FRR in donors ≥60 years old was (mean ± SD) 0.27 ± 0.11 versus 0.22 ± 0.09 mmHg/mL/min in donors <60 years (P = 0.042). Kidney survival was 88.2% versus 84% at 12 months and 60.7% versus 30.8% at 120 months (P = 0.067). For the group of recipients from donors ≥60 years, the FRR was 0.37 ± 0.08 mmHg/mL/min in the GFR <30 mL/min group versus 0.18 ± 0.06 mmHg/mL/min in the GFR ≥30 mL/min group (P < 0.001). The value FRR ≥0.3 mmHg/mL/min predicts 59-79% of GFR <30 mL/min [odds ratio = 2.16, 95% confidence interval (CI) 1.80-6.40; P < 0.001]. The predictive accuracy of FRR for GFR by ROC curve was 0.968 (95% CI). The best cut-off for FRR was 0.3 mmHg/mL/min to predict GFR at 6 months with a sensitivity of 67%, specificity of 100%, positive predictive value of 83% and negative predictive value of 92%. CONCLUSIONS Our results suggest that in uDCD donors the combination of donor age ≥60 years together with FRR ≥0.3 mmHg/mL/min could predict poor outcome at 6 months after transplantation in low immunological risk recipients.
Collapse
Affiliation(s)
- Rosana Gelpi
- Nephrology and Renal Transplant Department, Donation and Transplant Coordination Department, Hospital Clínic i Universitari de Barcelona, Barcelona, Spain
| | - David Paredes
- Nephrology and Renal Transplant Department, Donation and Transplant Coordination Department, Hospital Clínic i Universitari de Barcelona, Barcelona, Spain
| | - Camino Rodríguez-Villar
- Nephrology and Renal Transplant Department, Donation and Transplant Coordination Department, Hospital Clínic i Universitari de Barcelona, Barcelona, Spain
| | - Rebeca Roque
- Nephrology and Renal Transplant Department, Donation and Transplant Coordination Department, Hospital Clínic i Universitari de Barcelona, Barcelona, Spain
| | - Angel Ruiz
- Nephrology and Renal Transplant Department, Donation and Transplant Coordination Department, Hospital Clínic i Universitari de Barcelona, Barcelona, Spain
| | - Ramon Adalia
- Nephrology and Renal Transplant Department, Donation and Transplant Coordination Department, Hospital Clínic i Universitari de Barcelona, Barcelona, Spain
| | - Luis Peri-Cusí
- Nephrology and Renal Transplant Department, Donation and Transplant Coordination Department, Hospital Clínic i Universitari de Barcelona, Barcelona, Spain
| | - Manel Sole
- Nephrology and Renal Transplant Department, Donation and Transplant Coordination Department, Hospital Clínic i Universitari de Barcelona, Barcelona, Spain
| | - Federico Oppenheimer
- Nephrology and Renal Transplant Department, Donation and Transplant Coordination Department, Hospital Clínic i Universitari de Barcelona, Barcelona, Spain
| | - Fritz Diekmann
- Nephrology and Renal Transplant Department, Donation and Transplant Coordination Department, Hospital Clínic i Universitari de Barcelona, Barcelona, Spain
| |
Collapse
|
10
|
Rodríguez-Villar C, Paredes D, Roque R, Gelpi R, Ruíz A, Ventura-Aguiar P, Ferrer J, Diekmann F, Adalia R. Predictive and Comparative Study Between Clinic Consensus Document for Pancreas Acceptance and Predictive Value of Preprocurement Pancreas Allocation Suitability Score (P-PASS). Transplant Proc 2018; 51:365-368. [PMID: 30879542 DOI: 10.1016/j.transproceed.2018.10.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/07/2018] [Accepted: 10/23/2018] [Indexed: 11/17/2022]
Abstract
The strict selection of pancreas for transplant has forced the development of different documents to select the suitable organ in order to minimize the risks and complications of the transplant. In 2008, Eurotransplant published the Preprocurement Pancreas Allocation Suitability Score (P-PASS) for pretransplant selection. In 2001 the Hospital Clinic of Barcelona developed a Clinical Consensus Document (CCD). OBJECTIVES We aimed to analyze the predictive decision of the pancreas acceptance to offers received in the hospital, according to the CCD criteria and compare it with the recommended value of suitability for accepting the pancreas according to the P-PASS value. MATERIAL AND METHODS We performed a retrospective comparative study between the criteria of selection of the CCD for pancreas from 2016-2017 in comparison with the values obtained if the P-PASS had been used: ≤ 17, acceptance criteria and P-PASS; > 17, risk criteria. We defined the organ reported as rejected or accepted. The accepted organ could be procured and transplanted or discarded. RESULTS With the CCD criteria, 7 more organs were transplanted than if we only applied the potential P-PASS criteria. In contrast, P-PASS would have ruled out an additional 9% of pancreases in relation to CCD criteria. CONCLUSIONS According our experience, it is difficult to find an adequate prediction model to select pancreas for transplantation. The application of the DCC criteria increases the number of organs valid for transplantation. At present, new criteria should be re-evaluated within multicenter studies.
Collapse
Affiliation(s)
- C Rodríguez-Villar
- Donation and Transplant Coordination Section, Hospital Clinic, Barcelona, Spain.
| | - D Paredes
- Donation and Transplant Coordination Section, Hospital Clinic, Barcelona, Spain
| | - R Roque
- Donation and Transplant Coordination Section, Hospital Clinic, Barcelona, Spain
| | - R Gelpi
- Kidney Transplant Unit, Hospital Clinic, Barcelona, Spain
| | - A Ruíz
- Donation and Transplant Coordination Section, Hospital Clinic, Barcelona, Spain
| | | | - J Ferrer
- Hepatobiliopancreatic and Liver Transplant Department, Hospital Clinic, Barcelona, Spain
| | - F Diekmann
- Kidney Transplant Unit, Hospital Clinic, Barcelona, Spain
| | - R Adalia
- Donation and Transplant Coordination Section, Hospital Clinic, Barcelona, Spain
| |
Collapse
|
11
|
Roque R, Rodríguez-Villar C, Ruíz A, Paredes D, Gelpi R, Rodríguez S, García FJ, Adalia R. Relatives' Perception After Tissue Donation Experience: Results of a Postdonation Phone Survey. Transplant Proc 2018; 49:2296-2298. [PMID: 29198664 DOI: 10.1016/j.transproceed.2017.10.018] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
INTRODUCTION Postmortem tissue donation (TD) requires the establishment of strategies for family approach to clearly explain the characteristics of multi-tissue donation. In a tertiary university hospital with a long tradition of tissue generation, we designed a survey to be applied to tissue donor families to evaluate global hospital care, care from Transplant Coordinators (TC), quality and content of information given about TD, experience, and motivations after TD process. METHODOLOGY A prospective phone survey of 10 multiple-choice items was conducted to all TD relatives that agreed to donate one or more tissues. RESULTS From the 166 calls made to TD relatives, 75 (45%) were answered: 50 were cornea donors and 25 were multiple-tissues donors. None of the relatives denied participating, the rest were not found. No statistical differences in demographical variables were found between both types of TD. The hospital and TC care perception, the quality of the given information about the processes of TD, the postdonation experiences in terms of procedures, and the impression about body appearance for relatives regardless of the type of donation, corneas or multiple tissues, were evaluated as good or very good for most of the TD relatives. Our study showed that 83% of the family members would agree to donate again; 40% of the relatives were surprised to be offered the option to donate; 10% did not know if they would donate again. Solidarity was the leading reason for TD. CONCLUSION The relatives' perception of care is a critical component of the quality evaluation of the TD process. The global evaluation results support our strategies for family approach.
Collapse
Affiliation(s)
- R Roque
- Donation and Transplant Coordination Unit, Hospital Clínic Barcelona, Barcelona, Spain.
| | - C Rodríguez-Villar
- Donation and Transplant Coordination Unit, Hospital Clínic Barcelona, Barcelona, Spain
| | - A Ruíz
- Donation and Transplant Coordination Unit, Hospital Clínic Barcelona, Barcelona, Spain
| | - D Paredes
- Donation and Transplant Coordination Unit, Hospital Clínic Barcelona, Barcelona, Spain
| | - R Gelpi
- Donation and Transplant Coordination Unit, Hospital Clínic Barcelona, Barcelona, Spain
| | - S Rodríguez
- Donation and Transplant Coordination Unit, Hospital Clínic Barcelona, Barcelona, Spain
| | - F J García
- Donation and Transplant Coordination Unit, Hospital Clínic Barcelona, Barcelona, Spain
| | - R Adalia
- Donation and Transplant Coordination Unit, Hospital Clínic Barcelona, Barcelona, Spain
| |
Collapse
|
12
|
Gelpi R, Rodríguez-Villar C, Paredes D, Roque R, Ruiz A, Adalia R, de Sousa E, Revuelta I, Sole M, Martinez M, Navarro M, Lens S, Oppenheimer F, Diekmann F. Safety of hepatitis C virus (HCV)-treated donors for kidney transplantation excluding occult HCV infection through kidney biopsies. Transpl Int 2018; 31:938-939. [DOI: 10.1111/tri.13270] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Affiliation(s)
- Rosana Gelpi
- Renal Transplant Unit; Hospital Clinic de Barcelona; University of Barcelona; Barcelona Spain
- Donation and Transplant Coordination Section; Hospital Clinic de Barcelona; University of Barcelona; Barcelona Spain
| | - Camino Rodríguez-Villar
- Donation and Transplant Coordination Section; Hospital Clinic de Barcelona; University of Barcelona; Barcelona Spain
| | - David Paredes
- Donation and Transplant Coordination Section; Hospital Clinic de Barcelona; University of Barcelona; Barcelona Spain
| | - Rebeca Roque
- Donation and Transplant Coordination Section; Hospital Clinic de Barcelona; University of Barcelona; Barcelona Spain
| | - Angel Ruiz
- Donation and Transplant Coordination Section; Hospital Clinic de Barcelona; University of Barcelona; Barcelona Spain
| | - Ramon Adalia
- Donation and Transplant Coordination Section; Hospital Clinic de Barcelona; University of Barcelona; Barcelona Spain
| | - Erika de Sousa
- Renal Transplant Unit; Hospital Clinic de Barcelona; University of Barcelona; Barcelona Spain
| | - Ignacio Revuelta
- Renal Transplant Unit; Hospital Clinic de Barcelona; University of Barcelona; Barcelona Spain
| | - Manuel Sole
- Pathology Department; Hospital Clinic de Barcelona; University of Barcelona; Barcelona Spain
| | - Miguel Martinez
- Department of Clinical Microbiology; Barcelona Centre for International Health Research (CRESIB); Barcelona Spain
| | - Mireia Navarro
- Department of Clinical Microbiology; Barcelona Centre for International Health Research (CRESIB); Barcelona Spain
| | - Sabela Lens
- Liver Unit; IDIBAPS; CIBEREHD; University of Barcelona; Barcelona Spain
| | - Federico Oppenheimer
- Renal Transplant Unit; Hospital Clinic de Barcelona; University of Barcelona; Barcelona Spain
| | - Fritz Diekmann
- Renal Transplant Unit; Hospital Clinic de Barcelona; University of Barcelona; Barcelona Spain
| |
Collapse
|
13
|
Hernán Gómez Llambí H, Cao G, Donato M, Suárez D, Ottaviano G, Müller A, Buchholz B, Gelpi R, Otero-Losada M, Milei J. Left ventricular hypertrophy does not prevent heart failure in experimental hypertension. Int J Cardiol 2017; 238:57-65. [PMID: 28410843 DOI: 10.1016/j.ijcard.2017.03.109] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/21/2016] [Revised: 03/04/2017] [Accepted: 03/24/2017] [Indexed: 12/22/2022]
Abstract
BACKGROUND Left ventricular hypertrophy (LVH) secondary to hypertension has been accepted to prevent heart failure (HF) while paradoxically increasing cardiovascular morbi-mortality. OBJECTIVES To evaluate whether antihypertensive treatment inhibits LVH, restores beta-adrenergic response and affects myocardial oxidative metabolism. METHODS Ninety spontaneously hypertensive rats (SHR) were distributed into groups and treated (mg/kg, p.o.) with: losartan 30 (L), hydralazine 11 (H), rosuvastatin 10 (R), carvedilol 20 (C). Hypertension control group comprised 18 normotensive rats (Wistar-Kyoto, WKY). Following euthanasia at 16months, contractility was measured in 50% of rats (Langendorff system) before and after isoproterenol (Iso) 10-9M, 10-7M and 10-5M stimulation. Left ventricular weight (LVW) was measured in the remaining hearts, and normalized by BW. Expression of thioredoxin 1 (Trx-1), peroxyredoxin 2 (Prx-2), glutaredoxin 3 (Grx-3), caspase-3 and brain natriuretic peptide (BNP) was determined. RESULTS Systolic blood pressure (mmHg): 154±3 (L), 137±1 (H), 190±3 (R)*, 206±3 (SHR)*, 183±1 (C)**, and 141±1 (WKY) (*p<0.05 vs. L, H, WKY, **p<0.05 vs. L, H, WKY, SHR). LVW/BW was higher in SHR and R (p<0.05). Groups SHR, R and C evidenced baseline contractile depression. Response to Iso 10-5M was similar in WKY and L. Expression of Trx-1, Prx-2 and Grx-3 increased in C, H, R and L (p<0.01). CONCLUSIONS Present findings argue against the traditional idea and support that LVH might not be required to prevent HF. Increased expression of thioredoxins by antihypertensive treatment might be involved in protection from HF.
Collapse
Affiliation(s)
- H Hernán Gómez Llambí
- Institute of Cardiological Research, School of Medicine, University of Buenos Aires, UBA-CONICET, Buenos Aires, Argentina
| | - G Cao
- Institute of Cardiological Research, School of Medicine, University of Buenos Aires, UBA-CONICET, Buenos Aires, Argentina
| | - M Donato
- Institute of Cardiovascular Pathophysiology, School of Medicine, University of Buenos Aires, UBA-CONICET, Buenos Aires, Argentina
| | - D Suárez
- Institute of Cardiological Research, School of Medicine, University of Buenos Aires, UBA-CONICET, Buenos Aires, Argentina
| | - G Ottaviano
- Institute of Cardiological Research, School of Medicine, University of Buenos Aires, UBA-CONICET, Buenos Aires, Argentina
| | - A Müller
- Institute of Cardiological Research, School of Medicine, University of Buenos Aires, UBA-CONICET, Buenos Aires, Argentina
| | - B Buchholz
- Institute of Cardiovascular Pathophysiology, School of Medicine, University of Buenos Aires, UBA-CONICET, Buenos Aires, Argentina
| | - R Gelpi
- Institute of Cardiovascular Pathophysiology, School of Medicine, University of Buenos Aires, UBA-CONICET, Buenos Aires, Argentina
| | - M Otero-Losada
- Institute of Cardiological Research, School of Medicine, University of Buenos Aires, UBA-CONICET, Buenos Aires, Argentina.
| | - J Milei
- Institute of Cardiological Research, School of Medicine, University of Buenos Aires, UBA-CONICET, Buenos Aires, Argentina
| |
Collapse
|
14
|
Roque R, Rodriguez-Villar C, Ruiz A, Paredes D, Gelpi R, Garcia X, Vizcaíno F, Saavedra S, Rodríguez S, Quijada M, Bohils M, Adalia R. Quality Assessment of Postmortem Tissue Donors in a University Hospital: Detection and Generation Tissue Indicators. Transplant Proc 2016; 48:2859-2861. [DOI: 10.1016/j.transproceed.2016.08.040] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/07/2016] [Accepted: 08/04/2016] [Indexed: 12/21/2022]
|
15
|
Gelpi R, Cid J, Lozano M, Revuelta I, Sanchez-Escuredo A, Blasco M, de Souza E, Esforzado N, Torregrosa JV, Cofán F, Ricart MJ, Campistol JM, Oppenheimer F, Diekmann F. Desensitization in ABO-Incompatible Kidney Transplantation With Low ABO Iso-Agglutinin Titers. Transplant Proc 2016; 47:2340-3. [PMID: 26518921 DOI: 10.1016/j.transproceed.2015.08.021] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/09/2023]
Abstract
BACKGROUND In ABO-incompatible (ABOi) kidney transplantation (KT) with low iso-agglutinin (IG) titers (IGT), standard pre-conditioning treatment might be excessive. To try to answer this question, we evaluated the pre-conditioning requirements of a group of ABOi KT with low ABO IGT in our center. Our main objective was to assess desensitization requirements for ABOi KT with low IGT (<16) at Hospital Clinic of Barcelona from 2006 to 2014. METHODS A retrospective study of desensitization (rituximab and plasma exchange [PE]) requirements for ABOi KT with IGT <16 was conducted. RESULTS One and 5 years after KT, patient survival was 100%. Renal graft survival was 90% at 1 and 5 years after KT. Mean PE performed before KT was 1.7 (standard deviation [SD], 1.703); 50% of the patients did not receive PE after transplantation, 30% received 2 sessions of PE, and 20% received only 1. The average is 0.8 (SD, 0.91).Follow-up IG determinations remained with low titers (≤8/8). No rebounds of titers were observed during the first 4 to 6 months after transplantation. CONCLUSIONS Recipients with IGT ≤8 required none or only 1 PE session to reach acceptable titers (titers ≤4) to perform ABOi KT safely. This information is useful to assess the possibility of a minimized desensitization protocol in ABOi KT donors with low titers of IG to reduce adverse effects, reduce cost, and simplify pre-transplant logistics.
Collapse
Affiliation(s)
- R Gelpi
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - J Cid
- Apheresis Unit, Department of Hemotherapy and Hemostasis, Hospital Clinic, Barcelona, Catalonia, Spain
| | - M Lozano
- Apheresis Unit, Department of Hemotherapy and Hemostasis, Hospital Clinic, Barcelona, Catalonia, Spain
| | - I Revuelta
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - A Sanchez-Escuredo
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - M Blasco
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - E de Souza
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - N Esforzado
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - J V Torregrosa
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - F Cofán
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - M J Ricart
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - J M Campistol
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - F Oppenheimer
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain
| | - F Diekmann
- Department of Nephrology and Renal Transplantation, Hospital Clinic, Barcelona, Catalonia, Spain.
| |
Collapse
|
16
|
Coelho S, Ortíz F, Gelpi R, Koskinen P, Porta N, Bestard O, Melilli E, Taco O, Torras J, Honkanen E, Grinyó JM, Cruzado JM. Sterile leukocyturia is associated with interstitial fibrosis and tubular atrophy in kidney allograft protocol biopsies. Am J Transplant 2014; 14:908-15. [PMID: 24517324 DOI: 10.1111/ajt.12639] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/17/2013] [Revised: 12/13/2013] [Accepted: 12/29/2013] [Indexed: 01/25/2023]
Abstract
Kidney allograft interstitial fibrosis and tubular atrophy (IF/TA) is associated with a poorer renal function and outcome. In the current clinical practice, an early diagnosis can only be provided by invasive tests. We aimed to investigate the association of sterile leukocyturia with Banff criteria histological findings in kidney allograft protocol biopsies. We studied 348 allograft biopsies from two different European countries performed at 8.5 + 3.5 months after transplantation. In these cases, the presence of sterile leukocyturia (Leuc+, n = 70) or no leukocyturia (Leuc-, n = 278) was analyzed and related to Banff elementary lesions. Only IF/TA was significantly different between Leuc+ and Leuc- groups. IF/TA was present in 85.7% of Leuc+ and 27.7% of Leuc- patients (p < 0.001). IF/TA patients had higher serum creatinine and presence of proteinuria (p < 0.05). Independent predictors of IF/TA were donor age, donor male sex, serum creatinine and Leuc+ (hazard ratio 18.2; 95% confidence interval, 8.1-40.7). The positive predictive value of leukocyturia for predicting IF/TA was 85.7% whereas the negative predictive value was 72.3%. These studies suggest that leukocyturia is a noninvasive and low-cost test to identify IF/TA. An early diagnosis may allow timely interventional measures directed to minimize its impact and improve graft outcome.
Collapse
Affiliation(s)
- S Coelho
- Department of Nephrology, Hospital Fernando da Fonseca, Lisbon, Portugal
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
17
|
Ortiz F, Gelpi R, Koskinen P, Manonelles A, Raisanen-Sokolowski A, Carrera M, Honkanen E, Grinyo JM, Cruzado JM. IgA nephropathy recurs early in the graft when assessed by protocol biopsy. Nephrol Dial Transplant 2011; 27:2553-8. [DOI: 10.1093/ndt/gfr664] [Citation(s) in RCA: 65] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
18
|
Tchebotareva N, Bobkova I, Kozlovskaya L, Li O, Plaisier E, Terrier B, Lacraz A, Bridoux F, Huart A, Marie I, Launay D, Hummel A, Saint-Martin L, Bonnet F, Belenotti P, Kahn JE, Hinschberger O, Rullier P, Cacoub P, Casian A, Szpirt W, Jayne D, Walsh M, Haris A, Polner K, Aranyi J, Braunitzer H, Meran Z, Kaszas I, Mazanowska O, Koscielska-Kasprzak K, Kaminska D, Penar J, Zabinska M, Dziemianko I, Krajewska M, Klinger M, Marco H, Corica M, Picazo M, Arce Y, Llobet JM, Diaz M, Ballarin J, Kuroki A, Akizawa T, Papasotiriou M, Kalliakmani P, Huang L, Gerolymos M, Goumenos DS, Johnson TS, Ogahara S, Abe Y, Ito K, Watanabe M, Saito T, Saito T, Watanabe M, Ito K, Abe Y, Ogahara S, Nesen A, Topchii I, Semenovylh P, Galchinskaya V, Bantis C, Heering P, Kouri NM, Schwandt C, Rump LC, Ivens K, Nagasawa Y, Iio K, Fukuda S, Date Y, Iwatani H, Yamamoto R, Horii A, Inohara H, Imai E, Ohno H, Rakugi H, Rakugi Y, Sahin OZ, Gibyeli Genek D, Alkan Tasli F, Yavas H, Gurses S, Yeniay P, Uzum A, Ersoy R, Cirit M, Christou D, Molyneux K, Peracha J, Feehally J, Smith AC, Barratt J, Yamamoto R, Nagasawa Y, Shoji T, Katakami N, Ohtoshi K, Hayaishi-Okano R, Yamasaki Y, Yamauchi A, Tsubakihara Y, Imai E, Rakugi H, Isaka Y, Faria B, Vidinha J, Pego C, Garrido J, Lemos S, Lima C, Sorbo G, Lorga E, Sousa T, Yavas HH, Sahin OZ, Ozen KP, Gibyeli Genek D, Ersoy R, Alkan Tasli F, Yucel O, Cirit M, Wada Y, Ogata H, Yamamoto M, Ito H, Kinugasa E, Lundberg S, Lundahl J, Gunnarsson I, Jacobson S, Camilla R, Loiacono E, Dapra V, Morando L, Conrieri M, Bianciotto M, Bosetti FM, Gallo R, Peruzzi L, Amore A, Coppo R, Jeong K, Kim Y, Lee TW, Lee SH, Moon JY, Lee S, Ihm C, Komatsu H, Fujimoto S, Kikuchi M, Sato Y, Kitamura K, Sulikowska B, Johnson R, Grajewska M, Donderski R, Odrowaz-Sypniewska G, Manitius J, Amore A, Camilla R, Morando L, Peruzzi L, Rollino C, Quarello F, Colla L, Segoloni G, Caramello E, Cravero R, Quaglia M, Stratta P, Mazzucco G, Coppo R, Coppo R, Grcevska L, Petrusevska G, Nikolov V, Polenakovic M, Lee KW, Ham YR, Jang WI, Jung JY, Jang DS, Chung S, Choi DE, Na KR, Shin YT, Sulikowska B, Johnson R, Grajewska M, Donderski R, Odrowaz-Sypniewska G, Manitius J, Pasquariello A, Innocenti M, Pasquariello G, Mattei P, Colombini E, Ricchiuti G, Sami N, Cupisti A, Rocchetti MT, Di Paolo S, Tamma G, Lasorsa D, Suriano IV, D'Apollo A, Papale M, Mastrofrancesco L, Grandaliano G, Svelto M, Valenti G, Gesualdo L, Wang C, Li Y, Jia N, Fan J, Vigotti FN, Daidola G, Colla L, Besso L, Segoloni GP, Rocchetti MT, Papale M, Di Paolo S, Vocino G, Suriano IV, D'Apollo A, Grandaliano G, Gesualdo L, Berthoux F, Mohey H, Laurent B, Mariat C, Afiani A, Thibaudin L, Rivera F, Segarra A, Praga M, Vozmediano C, Rivera F, Lopez JM, Hernandez D, Pesickova S, Rysava R, Lenicek M, Potlukova E, Jancova E, Vitek L, Honsova E, Zavada J, Svarcova J, Kalousova M, Trendelenburg M, Tesar V, Li X, Ren H, Zhang W, Pan X, Zhang Q, Chen X, Xu Y, Shen P, Chen N, Hruskova Z, Mareckova H, Svobodova B, Jancova E, Bednarova V, Rysava R, Tesar V, Bobrova L, Kozlovskaya N, Khafizova E, Meteleva N, Shakhnova E, Alsuwaida A, Hussain S, Alghonaim M, AlOudah N, Ullah A, Kfoury H, Lorusso P, Bottai A, Cipollini I, Giorgetti M, Barsotti G, Goplani K, Kaswan K, Gera D, Patel H, Gumber M, Shah P, Vanikar A, Trivedi H, Gluhovschi C, Gluhovschi G, Potencz E, Lazar E, Trandafirescu V, Petrica L, Velciov S, Bozdog G, Bob F, Gadalean F, Vernic C, Cioca D, Bantis C, Heering P, Stangou M, Kouri NM, Schwandt C, Memmos D, Rump LC, Ivens K, Tofik R, Rippe B, Torffvit O, Bakoush O, Silska M, Lipkowska K, Warzywoda A, Soltysiak J, Blumczynski A, Musielak A, Ostalska-Nowicka D, Zachwieja J, Spartalis M, Stangou M, Pliakos K, Oikonomidou D, Pantzaki A, Rizopoulou E, Efstratiadis G, Memmos D, Okino VT, Moyses Neto M, Silva GEB, Vieira Neto O, Romao EA, Coelho EB, Dantas M, Liakou H, Stangou M, Ekonomidou D, Pantzaki A, Patinakis P, Sigounas V, Efstratiadis G, Memmos D, Shvetsov M, Bobkova I, Zheng A, Li O, Chebotareva N, Kamyshova E, Rudenko T, Gelpi R, Navarro I, Ngango L, Poveda R, Goma M, Torras J, Grinyo JM, Fulladosa X, Wang Y, Ivany J, Jardine M, Zhong F, Wang W, Ren H, Xie Y, Huang Q, Chen N, Chiappini MG, Di Girolamo M, Grosso A, Muzi L, Panetta V, Khafizova E, Kozlovskaya N, Bobrova L, Bobkova I, Avdonin P, Gluhovschi C, Gluhovschi G, Potencz E, Lazar E, Trandafirescu V, Petrica L, Velciov S, Bozdog G, Bob F, Gadalean F, Vernic C, Cioca D, Ito M, Kimachi M, Nishio S, Koike T, Choi H, Cho AJ, Jang HR, Lee JE, Huh W, Kim DJ, Oh HY, Kim YG. Clinical Nephrology: primary and secondary glomerulonephritis. Clin Kidney J 2011. [DOI: 10.1093/ndtplus/4.s2.35] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
19
|
Ruiz G, Chirife R, Tentori M, Dasso D, Gelpi R, Perfetto J. 223 The bradycardia-hypotension reaction during head-up tilt test in patients with syncope: prevalence and value of blood pressure and heart rate behavior during the early stage of the test. Europace 2005. [DOI: 10.1016/eupace/7.supplement_1.45-a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Affiliation(s)
- G.A. Ruiz
- Hospital Juan A. Fernandez, Florida, Argentina
| | - R. Chirife
- Hospital Juan A Fernandez, Cardiology, Buenos Aires, Argentina
| | - M.C. Tentori
- Hospital Juan A Fernandez, Cardiology, Buenos Aires, Argentina
| | - D. Dasso
- Hospital Juan A Fernandez, Cardiology, Buenos Aires, Argentina
| | - R. Gelpi
- Facultad de Medicina. UBA, Instituto Fisiopatologia Cardiovascula, Buenos Aires, Argentina
| | - J.C. Perfetto
- Facultad de Ingenieria, UBA, Biomedicina, Buenos Aires, Argentina
| |
Collapse
|
20
|
Ruiz G, Chirife R, Tentori M, Perfetto J, Dasso D, Gelpi R. 885 The bradycardia-hypotension reaction during head-up tilt test: clinical and hemodynamic characteristics related to blood pressure and heart rate behavior during the early stage of the test. Europace 2005. [DOI: 10.1016/eupace/7.supplement_1.216-a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Affiliation(s)
- G.A. Ruiz
- Hospital Juan A. Fernandez, Florida, Argentina
| | - R. Chirife
- Hospital Juan A Fernandez, cardiology, Buenos Aires, Argentina
| | - M.C. Tentori
- Hospital Juan A Fernandez, cardiology, Buenos Aires, Argentina
| | - J.C. Perfetto
- Facultad de Ingenieria, UBA, Biomedicina, Buenos Aires, Argentina
| | - D. Dasso
- Hospital Juan A Fernandez, cardiology, Buenos Aires, Argentina
| | - R. Gelpi
- UBA, Facultad de Medicina, Buenos Aires, Argentina
| |
Collapse
|
21
|
Ruiz G, Perfetto J, Gallino S, Chirife R, Tentori M, Guillardot A, Gelpi R. A01-2 Detecting baroreflex activity by a sequential analysis during head-up tilt test in young women with syncope. Europace 2003. [DOI: 10.1016/eupace/4.supplement_2.b1-a] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022] Open
Affiliation(s)
- G.A. Ruiz
- Hospital De Agudos Juan A Fernandez. Facultad De Ingenieria Uba.
Buenos Aires. Argentina
| | - J.C. Perfetto
- Hospital De Agudos Juan A Fernandez. Facultad De Ingenieria Uba.
Buenos Aires. Argentina
| | - S. Gallino
- Hospital De Agudos Juan A Fernandez. Facultad De Ingenieria Uba.
Buenos Aires. Argentina
| | - R. Chirife
- Hospital De Agudos Juan A Fernandez. Facultad De Ingenieria Uba.
Buenos Aires. Argentina
| | - M.C. Tentori
- Hospital De Agudos Juan A Fernandez. Facultad De Ingenieria Uba.
Buenos Aires. Argentina
| | - A. Guillardot
- Hospital De Agudos Juan A Fernandez. Facultad De Ingenieria Uba.
Buenos Aires. Argentina
| | - R. Gelpi
- Hospital De Agudos Juan A Fernandez. Facultad De Ingenieria Uba.
Buenos Aires. Argentina
| |
Collapse
|
22
|
Ruiz G, Perfetto J, Gallino S, Chirife R, Guillardot A, Tentori M, Gelpi R. A13-2 Identification of negative feedback, positive feedback and feed foward sequences during tilt test in young women with syncope. Europace 2003. [DOI: 10.1016/eupace/4.supplement_2.b19-b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Affiliation(s)
- G.A. Ruiz
- Hospital De Agudos Juan A Fernandez, Facultad De Ingenieria, Uba, Buenos Aires, Argentina
| | - J.C. Perfetto
- Hospital De Agudos Juan A Fernandez, Facultad De Ingenieria, Uba, Buenos Aires, Argentina
| | - S. Gallino
- Hospital De Agudos Juan A Fernandez, Facultad De Ingenieria, Uba, Buenos Aires, Argentina
| | - R. Chirife
- Hospital De Agudos Juan A Fernandez, Facultad De Ingenieria, Uba, Buenos Aires, Argentina
| | - A. Guillardot
- Hospital De Agudos Juan A Fernandez, Facultad De Ingenieria, Uba, Buenos Aires, Argentina
| | - M.C. Tentori
- Hospital De Agudos Juan A Fernandez, Facultad De Ingenieria, Uba, Buenos Aires, Argentina
| | - R. Gelpi
- Hospital De Agudos Juan A Fernandez, Facultad De Ingenieria, Uba, Buenos Aires, Argentina
| |
Collapse
|
23
|
Cabeza Meckert PM, Cazzulo JJ, Segura EL, Esteva M, Ruiz AM, Gelpi R, Laguens RP. Induction of heart alterations by immunization with subcellular fractions from Crithidia fasciculata. Experientia 1984; 40:171-3. [PMID: 6365581 DOI: 10.1007/bf01963583] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/19/2023]
Abstract
Immunization of mice with subcellular fractions of C. fasciculata led to myocarditis and electrocardiographic alterations similar to those induced by immunization with T. cruzi, the etiological agent of Chagas' disease, suggesting the presence of similar cardiotoxic antigens in both trypanosomatid flagellates.
Collapse
|